| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 155.95B | 159.23B | 135.01B | 124.08B | 83.42B | 98.40B |
| Gross Profit | 33.73B | 36.31B | 22.92B | 15.01B | -4.13B | -5.09B |
| EBITDA | 30.14B | 32.91B | 20.08B | 13.17B | -5.58B | -6.30B |
| Net Income | 21.11B | 26.25B | 19.95B | 11.19B | -8.42B | -18.78B |
Balance Sheet | ||||||
| Total Assets | 222.38B | 209.04B | 174.79B | 124.90B | 123.72B | 111.56B |
| Cash, Cash Equivalents and Short-Term Investments | 99.91B | 90.14B | 55.39B | 29.46B | 25.28B | 13.51B |
| Total Debt | 17.62B | 18.51B | 13.57B | 11.87B | 15.33B | 17.82B |
| Total Liabilities | 112.18B | 103.89B | 94.89B | 74.84B | 86.55B | 71.20B |
| Stockholders Equity | 109.82B | 104.76B | 79.68B | 49.96B | 37.17B | 40.36B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 32.42B | 25.61B | 7.10B | 13.65B | -30.41B |
| Operating Cash Flow | 0.00 | 37.73B | 27.41B | 9.00B | 15.10B | -26.64B |
| Investing Cash Flow | 0.00 | -5.26B | -1.92B | -1.26B | -715.00M | -4.07B |
| Financing Cash Flow | 0.00 | 2.29B | 571.00M | -3.38B | -2.50B | -124.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥279.55B | 8.58 | 16.64% | 1.36% | -3.13% | -38.44% | |
72 Outperform | ¥564.18B | 17.86 | 13.69% | 0.60% | 14.51% | -39.56% | |
70 Outperform | ¥202.24B | -49.70 | ― | 2.41% | 4.17% | -43.52% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥170.77B | 8.92 | 9.14% | 2.84% | 3.10% | 20.79% | |
63 Neutral | ¥20.29B | 12.29 | ― | 0.27% | -5.08% | 85.43% | |
60 Neutral | ¥3.77B | -19.32 | ― | 0.67% | -7.20% | -77.04% |